EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Linezolid in enterococcal urinary tract infection: a multicentre study

Léa Malinowski, Souheil Zayet, Myriam Chiaruzzi, Benjamin Lefevre, Guillaume Baronnet, Mathieu Blot, Timothée Klopfenstein, Lionel Piroth, Catherine Chirouze, Albert Sotto, Kevin Bouiller

European Journal of Clinical Microbiology & Infectious Diseases · 2024

DOI: 10.1007/s10096-024-04923-7 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2024. Verfasst von Léa Malinowski und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of infectious and tropical diseases, Besançon University Hospital, Besançon, F-25000, France. Hauptthemen laut MEDLINE: Linezolid, Urinary Tract Infections, Anti-Bacterial Agents, Gram-Positive Bacterial Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Few data have been published on the efficacy of linezolid in enterococcal urinary tract infection (e-UTI). The aims of this study were to describe the characteristics of patients with enterococci UTI treated with linezolid, and to evaluate the efficacy and the tolerance of linezolid treatment. METHODS: An observational multicentre retrospective study was conducted in 5 hospitals in France. Patients were included if they met the following criteria: ≥18 years, clinical and microbiological criteria for enterococcal UTI and linezolid treatment > 48 h. Primary outcome was clinical failure. RESULTS: Eighty-one patients were included between January 2015 and December 2021. The median age was 73.0 [64; 83] years and 47 (58%) were men. The median Charlson comorbidity index was 3.00 [2; 6]. E. faecium was reported in 65 (80%) cases and E. faecalis in 26 cases (32%). Polymicrobial infections occurred in 41 (51%) cases. No enterococci was resistant to vancomycin. Before linezolid prescription an empiric antimicrobial treatment was started in 48 (59%) cases and was effective against enterococci in 19/48 (39.5%) patients for a median of 3.5 days [2.0; 4.0]. The median duration of linezolid antibiotic treatment was 13 days [10; 14]. Three adverse events were reported, none were serious but one led to discontinuation of treatment. Treatment failure was reported in 2 cases (2.5%). CONCLUSION: This study provides evidence for efficacy and safety of linezolid in enterococcal UTI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LinezolidUrinary Tract InfectionsAnti-Bacterial AgentsGram-Positive Bacterial InfectionsHumansMaleAgedFemaleRetrospective StudiesMiddle AgedAged, 80 and overFranceEnterococcus faecalisEnterococcusTreatment OutcomeEnterococcus faecium

Stichwörter der Autor:innen

Enterococcus faecalisEnterococcus faeciumEnterococcusLinezolidUrinary tract infection

Substanzen

LinezolidAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of infectious and tropical diseases, Besançon University Hospital, Besançon, F-25000, France.
  • Department of Infectious Diseases, Nord Franche-Comté Hospital, Trevenans, 90400, France.
  • Department Infectious and Tropical Diseases, Nimes University Hospital, Nîmes, France.
  • Department Infectious and Tropical Diseases, Lorraine University, CHRU-Nancy, Nancy, F- 54000, France.
  • Lorraine University, CHRU-Nancy, INSPIIRE, Inserm, Nancy, F-54000, France.
  • Department of Infectious Diseases, Dijon-Bourgogne University Hospital, Dijon, France.

Zitieren

APA

Malinowski, L., Zayet, S., Chiaruzzi, M., Lefevre, B., Baronnet, G., Blot, M., Klopfenstein, T., Piroth, L., Chirouze, C., Sotto, A., & Bouiller, K. (2024). Linezolid in enterococcal urinary tract infection: a multicentre study. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-024-04923-7

Vancouver

Malinowski L, Zayet S, Chiaruzzi M, Lefevre B, Baronnet G, Blot M, et al. Linezolid in enterococcal urinary tract infection: a multicentre study. European Journal of Clinical Microbiology & Infectious Diseases. 2024. doi:10.1007/s10096-024-04923-7

BibTeX
@article{Malinowski2024,
  author = {Malinowski, Léa and Zayet, Souheil and Chiaruzzi, Myriam and Lefevre, Benjamin and Baronnet, Guillaume and Blot, Mathieu and Klopfenstein, Timothée and Piroth, Lionel and Chirouze, Catherine and Sotto, Albert and Bouiller, Kevin},
  title = {Linezolid in enterococcal urinary tract infection: a multicentre study},
  journal = {European Journal of Clinical Microbiology & Infectious Diseases},
  year = {2024},
  doi = {10.1007/s10096-024-04923-7}
}
Kostenlos starten →